The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Garmin, Synaptics, and QuantumScape blend device hardware, AI-ready tech, and next-gen batteries in a low-profile tri...
Ripple Prime gains a $200 million asset-based debt facility to push broader margin lending for institutions, signalin...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
A coalition of more than 200 crypto firms is urging lawmakers to pass the Digital Asset Market Clarity Act. If it bec...
Jim Cramer asserts Five Below still has upside after a strong rally, driven by Winnie Park’s turnaround. The retailer...
Beyond Meat faces headwinds, but a protein drinks turnaround catalyst could change the game. This article breaks down...
In a volatile session, AT&T tumbled after a Supreme Court ruling favored the FCC on a data-privacy case, while major ...
Senate lawmakers move to investigate a UAE-backed investment in a Trump-linked crypto venture, signaling a potential ...
The CAAP 2026 earnings call offers more than quarterly results. This guide breaks down revenue drivers, margins, and ...
SNDL investors are keenly watching Q4 2025 earnings for a read on revenue mix, cost discipline, and debt strategy. Th...